{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:53:41Z","timestamp":1778964821657,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":752,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jtct.2021.01.021","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:53:08Z","timestamp":1611834788000},"page":"437.e1-437.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"Nao","family":"Tanizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Makuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhito","family":"Takakuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asao","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.01.021_bib0001","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00415-019-09578-5","article-title":"Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT","volume":"267","author":"Schmidt-Hieber","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0002","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00415-019-09372-3","article-title":"Neurological adverse events post-allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality","volume":"266","author":"Sakellari","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0003","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ejh.13489","article-title":"Major central nervous system complications after allogeneic stem cell transplantation: a large retrospective study on 888 consecutive adult patients","volume":"105","author":"Mannina","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/bmt.2017.239","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact","volume":"53","author":"Dowling","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12185-019-02624-y","article-title":"Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome","volume":"109","author":"Lin","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0006","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.bbmt.2017.05.033","article-title":"Posterior reversible encephalopathy syndrome after hematopoietic cell transplantation in children with hemoglobinopathies","volume":"23","author":"Gaziev","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0007","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/bmt.2014.182","article-title":"Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children","volume":"49","author":"Zama","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0008","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/ejh.12855","article-title":"Viral encephalitis after haploidentical hematopoietic stem cell transplantation: causative viral spectrum, characteristics, and risk factors","volume":"98","author":"Zhang","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0009","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bmt.2017.175","article-title":"Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Ogata","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/01.wnl.0000265591.10200.d7","article-title":"Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6","volume":"69","author":"Seeley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2021.01.021_bib0011","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0012","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/QCO.0000000000000592","article-title":"Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies","volume":"32","author":"Hill","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jtct.2021.01.021_bib0013","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0014","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1073\/pnas.0702023104","article-title":"Regulation of CNS synapses by neuronal MHC class I","volume":"104","author":"Goddard","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2021.01.021_bib0015","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2021.01.021_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-8993(90)91496-4","article-title":"Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease","volume":"523","author":"Tooyama","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.jtct.2021.01.021_bib0017","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2014-01-547612","article-title":"CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis","volume":"123","author":"Kaliyaperumal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.01.021_bib0018","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2012-09-456590","article-title":"The central nervous system is a target of acute graft-versus-host disease in mice","volume":"121","author":"Hartrampf","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.01.021_bib0019","doi-asserted-by":"crossref","first-page":"e8303","DOI":"10.1097\/MD.0000000000008303","article-title":"Case report. Central nervous system involvement of human graft-versus-host disease: report of 7 cases and a review of literature","volume":"96","author":"Ruggiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtct.2021.01.021_bib0020","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1200\/JCO.2009.21.7919","article-title":"Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation","volume":"27","author":"Saad","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bmt.2017.207","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","volume":"53","author":"Khosla","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2016.232","article-title":"Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation","volume":"52","author":"Straathof","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0023","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbmt.2016.12.632","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Maffini","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0024","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.01.021_bib0025","unstructured":"Ethical guidelines for medical and health research involving human subjects. Available at: https:\/\/www.lifescience.mext.go.jp\/files\/pdf\/n2181_01.pdf. Accessed 26 February 2021."},{"key":"10.1016\/j.jtct.2021.01.021_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003357","article-title":"Interactive web application for plotting personalized prognosis prediction curves in allogeneic hematopoietic cell transplantation using machine learning [e-pub ahead of print]","author":"Okamura","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2021.01.021_bib0027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbmt.2019.12.765","article-title":"Donor KIR2DS1-mediated decreased relapse and improved survival depending on remission status at HLA-haploidentical transplantation with post-transplantation cyclophosphamide","volume":"26","author":"Ido","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0028","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/bcp.13303","article-title":"Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation","volume":"83","author":"Nishimoto","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0029","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/10428194.2016.1262034","article-title":"Diagnostic value of serum ferritin and the risk factors and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation","volume":"58","author":"Nanno","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2021.01.021_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0031","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.01.021_bib0032","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0033","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0034","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2021.01.021_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0036","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.jtct.2021.01.021_bib0037","unstructured":"National Cancer Institute. Cancer Therapy Evaluation Program (CTEP). Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50. Accessed January 20, 2021."},{"key":"10.1016\/j.jtct.2021.01.021_bib0038","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.01.021_bib0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2021.01.021_bib0041","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48","author":"Iacobelli","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1 suppl","key":"10.1016\/j.jtct.2021.01.021_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbmt.2008.10.003","article-title":"Statistical considerations in studies of late effects in HCT","volume":"15","author":"Storer","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0043","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.01.021_bib0044","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ije\/25.6.1107","article-title":"Basic methods for sensitivity analysis of biases","volume":"25","author":"Greenland","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software EZR for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0046","series-title":"Multivariable Analysis: a Practical Guide for Clinicians and Public Health Researchers","first-page":"93","author":"Katz","year":"2011"},{"key":"10.1016\/j.jtct.2021.01.021_bib0047","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtct.2021.01.021_bib0048","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajh.23402","article-title":"Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation","volume":"88","author":"Hammerstrom","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0049","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease\u2014biological process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.01.021_bib0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fneur.2015.00163","article-title":"CD8+ T cell-mediated neuronal dysfunction and degeneration in limbic encephalitis","volume":"6","author":"Ehling","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0051","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.4049\/jimmunol.1102998","article-title":"Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus","volume":"188","author":"Scheikl","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0052","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","article-title":"Neurobehavioral outcomes in autoimmune encephalitis","volume":"312","author":"Yeshokumar","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0053","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtct.2021.01.021_bib0054","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","article-title":"Plasma exchange in pediatric anti-NMDAR encephalitis: a systematic review","volume":"38","author":"Suppiej","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.jtct.2021.01.021_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2021.01.021_bib0056","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jtct.2021.01.021_bib0057","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1634\/stemcells.2008-0116","article-title":"Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem\/progenitor cells","volume":"26","author":"Johansson","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jtct.2021.01.021_bib0058","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurad.2009.10.001","article-title":"EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation","volume":"37","author":"Kremer","year":"2010","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0059","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2015.05.011","article-title":"Autoimmune encephalitis following bone marrow transplantation","volume":"53","author":"Rathore","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12185-020-02859-0","article-title":"Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation","volume":"112","author":"Toda","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0061","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1399-0012.2009.01181.x","article-title":"Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation","volume":"24","author":"Yanagimachi","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2021.01.021_bib0062","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.410400511","article-title":"Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures","volume":"40","author":"McDonald","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0063","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(00)00554-3","article-title":"Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus","volume":"66","author":"Kochi","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jtct.2021.01.021_bib0064","first-page":"455","article-title":"Cyclosporin-induced endothelial cell injury","volume":"55","author":"Zoja","year":"1986","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtct.2021.01.021_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.healun.2010.08.001","article-title":"Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment","volume":"30","author":"Ramzy","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"1 suppl","key":"10.1016\/j.jtct.2021.01.021_bib0066","first-page":"I214","article-title":"Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine","volume":"114","author":"Ramzy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2021.01.021_bib0067","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0006-2952(90)90295-V","article-title":"Inhibition of prostacyclin formation by cyclosporin is not due to reduced availability of arachidonic acid in membrane phospholipids of cultured human endothelial cells","volume":"39","author":"Brown","year":"1990","journal-title":"Biochem Pharmacol"},{"issue":"1 Pt 2","key":"10.1016\/j.jtct.2021.01.021_bib0068","first-page":"1178","article-title":"Cyclosporine inhibits prostacyclin production by cultured human endothelial cells","volume":"19","author":"Brown","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2021.01.021_bib0069","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2017.12.013","article-title":"Immune dysregulation in myelodysplastic syndrome: clinical features, pathogenesis and therapeutic strategies","volume":"122","author":"Wang","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtct.2021.01.021_bib0070","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00277-018-3472-9","article-title":"Autoimmune manifestations associated with myelodysplastic syndromes","volume":"97","author":"Grignano","year":"2018","journal-title":"Ann Hematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:30Z","timestamp":1763002830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721006266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2666636721006266"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.01.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}